Royal Bank Of Canada Isoray, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	N/A	595 New	595 $0
Q1 2024 May 15, 2024	BUY	N/A	366 Added 159.83%	595 $0
Q4 2023 Feb 14, 2024	SELL	N/A	-2,000 Reduced 89.73%	229 $0
Q3 2023 Nov 14, 2023	BUY	N/A	1,967 Added 750.76%	2,229 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.0 - $0.69 $0 - $17,221	-24,959 Reduced 98.96%	262 $0
Q1 2023 May 15, 2023	BUY	$0.0 - $0.67 $0 - $28	42 Added 0.17%	25,221 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.24 - $0.4 $9 - $15	38 Added 0.15%	25,179 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.22 - $0.43 $31 - $60	141 Added 0.56%	25,141 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.37 $34 - $49	-134 Reduced 0.53%	25,000 $8,000
Q1 2022 May 16, 2022	SELL	$0.31 - $0.41 $172 - $228	-558 Reduced 2.17%	25,134 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.68 $383 - $686	-1,009 Reduced 3.78%	25,692 $10,000
Q3 2021 Nov 15, 2021	SELL	$0.58 - $0.79 $4,813 - $6,556	-8,299 Reduced 23.71%	26,701 $17,000
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.15 $26,250 - $40,250	35,000 New	35,000 $28,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.